These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 29349870)

  • 21. Physiologically based pharmacokinetic (PBPK) modeling and simulation: applications in lead optimization.
    Peters SA; Ungell AL; Dolgos H
    Curr Opin Drug Discov Devel; 2009 Jul; 12(4):509-18. PubMed ID: 19562647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of drug-drug interaction potential using physiologically based pharmacokinetic modeling.
    Min JS; Bae SK
    Arch Pharm Res; 2017 Dec; 40(12):1356-1379. PubMed ID: 29079968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Physiologically Based Pharmacokinetic Models to Predict Maternal Pharmacokinetics and Fetal Exposure to Emtricitabine and Acyclovir.
    Liu XI; Momper JD; Rakhmanina N; van den Anker JN; Green DJ; Burckart GJ; Best BM; Mirochnick M; Capparelli EV; Dallmann A
    J Clin Pharmacol; 2020 Feb; 60(2):240-255. PubMed ID: 31489678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variation of drug kinetics in pregnancy.
    Pavek P; Ceckova M; Staud F
    Curr Drug Metab; 2009 Jun; 10(5):520-9. PubMed ID: 19689248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physiologically Based Pharmacokinetic Modeling of Drug Transporters to Facilitate Individualized Dose Prediction.
    Galetin A; Zhao P; Huang SM
    J Pharm Sci; 2017 Sep; 106(9):2204-2208. PubMed ID: 28390843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A simplified PBPK modeling approach for prediction of pharmacokinetics of four primarily renally excreted and CYP3A metabolized compounds during pregnancy.
    Xia B; Heimbach T; Gollen R; Nanavati C; He H
    AAPS J; 2013 Oct; 15(4):1012-24. PubMed ID: 23835676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a Novel Maternal-Fetal Physiologically Based Pharmacokinetic Model II: Verification of the model for passive placental permeability drugs.
    Zhang Z; Unadkat JD
    Drug Metab Dispos; 2017 Aug; 45(8):939-946. PubMed ID: 28049636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Application of Physiologically Based Pharmacokinetic Modeling to Predict the Role of Drug Transporters: Scientific and Regulatory Perspectives.
    Pan Y; Hsu V; Grimstein M; Zhang L; Arya V; Sinha V; Grillo JA; Zhao P
    J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S122-31. PubMed ID: 27385170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug dosing during pregnancy-opportunities for physiologically based pharmacokinetic models.
    Abduljalil K; Badhan RKS
    J Pharmacokinet Pharmacodyn; 2020 Aug; 47(4):319-340. PubMed ID: 32592111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Maternal-Fetal Pharmacology of Drugs: A Review of Current Status of the Application of Physiologically Based Pharmacokinetic Models.
    Chaphekar N; Dodeja P; Shaik IH; Caritis S; Venkataramanan R
    Front Pediatr; 2021; 9():733823. PubMed ID: 34805038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drugs that affect the fetus and newborn infant via the placenta or breast milk.
    Ostrea EM; Mantaring JB; Silvestre MA
    Pediatr Clin North Am; 2004 Jun; 51(3):539-79, vii. PubMed ID: 15157585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physiologically based predictions of the impact of inhibition of intestinal and hepatic metabolism on human pharmacokinetics of CYP3A substrates.
    Fenneteau F; Poulin P; Nekka F
    J Pharm Sci; 2010 Jan; 99(1):486-514. PubMed ID: 19479982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physiologically-Based Pharmacokinetic Models for Evaluating Membrane Transporter Mediated Drug-Drug Interactions: Current Capabilities, Case Studies, Future Opportunities, and Recommendations.
    Taskar KS; Pilla Reddy V; Burt H; Posada MM; Varma M; Zheng M; Ullah M; Emami Riedmaier A; Umehara KI; Snoeys J; Nakakariya M; Chu X; Beneton M; Chen Y; Huth F; Narayanan R; Mukherjee D; Dixit V; Sugiyama Y; Neuhoff S
    Clin Pharmacol Ther; 2020 May; 107(5):1082-1115. PubMed ID: 31628859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of Quantitative Clinical Pharmacology in Pediatric Approval and Labeling.
    Mehrotra N; Bhattaram A; Earp JC; Florian J; Krudys K; Lee JE; Lee JY; Liu J; Mulugeta Y; Yu J; Zhao P; Sinha V
    Drug Metab Dispos; 2016 Jul; 44(7):924-33. PubMed ID: 27079249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Physiologically-Based Pharmacokinetic Model to Predict Human Fetal Exposure for a Drug Metabolized by Several CYP450 Pathways.
    De Sousa Mendes M; Lui G; Zheng Y; Pressiat C; Hirt D; Valade E; Bouazza N; Foissac F; Blanche S; Treluyer JM; Urien S; Benaboud S
    Clin Pharmacokinet; 2017 May; 56(5):537-550. PubMed ID: 27766562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pediatric Dose Selection and Utility of PBPK in Determining Dose.
    Templeton IE; Jones NS; Musib L
    AAPS J; 2018 Feb; 20(2):31. PubMed ID: 29441439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physiologically based pharmacokinetic (PBPK) modeling in children.
    Barrett JS; Della Casa Alberighi O; Läer S; Meibohm B
    Clin Pharmacol Ther; 2012 Jul; 92(1):40-9. PubMed ID: 22669290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-clinical Models to Determine Drug Passage into Human Breast Milk.
    Ventrella D; Forni M; Bacci ML; Annaert P
    Curr Pharm Des; 2019; 25(5):534-548. PubMed ID: 30894104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physiological-based pharmacokinetic modeling trends in pharmaceutical drug development over the last 20-years; in-depth analysis of applications, organizations, and platforms.
    El-Khateeb E; Burkhill S; Murby S; Amirat H; Rostami-Hodjegan A; Ahmad A
    Biopharm Drug Dispos; 2021 Apr; 42(4):107-117. PubMed ID: 33325034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of Maternal and Fetoplacental Concentrations of Cefazolin, Cefuroxime, and Amoxicillin during Pregnancy Using Bottom-Up Physiologically Based Pharmacokinetic Models.
    Abduljalil K; Ning J; Pansari A; Pan X; Jamei M
    Drug Metab Dispos; 2022 Apr; 50(4):386-400. PubMed ID: 35046066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.